Abstract
5060 Background: Cyclooxygenase-2 (COX-2) expression is associated with a poor chance of response to chemotherapy and poor prognosis in ovarian cancer (OC). Celecoxib, an orally active COX-2 inhibi...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have